MICHAEL WILLIAMS
Nursing at Medical Center Blvd, Winston Salem, NC

License number

North Carolina 244796

Personal information

See more information about MICHAEL WILLIAMS at radaris.com

Name

Address

Phone

Michael Von Williams, age 68

484 Bescher Chapel Rd, Trinity, NC 27370

(336) 241-2488

Michael Von Williams, age 67

4805 Kaycee Ct, Raleigh, NC 27616

(919) 981-0826

Michael Von Williams, age 55

480 Wetmore Rd, Woodleaf, NC 27054

Michael Von Williams, age 36

4906 Hampton Meadows Rd, Monroe, NC 28110

Michael Von Williams, age 70

4892 Giles Rd, Lexington, NC 27295

(336) 853-9971

Professional information

Pharmaceutical Development Management

Position:

Executive Director, Manufacturing at Salix Pharmaceuticals, Inc.

Location:

Winston Salem, North Carolina

Industry:

Pharmaceuticals

Work:

Salix Pharmaceuticals, Inc. - Raleigh-Durham, North Carolina Area since 2012 - Executive Director, Manufacturing Targacept, Inc - Winston-Salem, NC 2006 - 2012 - Director PRD - Principal Sci Wyeth Consumer Healthcare - Richmond, VA 2000 - 2006 - Assistant Vice President PDC (Pharmaceutical Development Center - Charleston, SC 1995 - 2000 - Director of Operations Solvay Pharmaceuticals - Marietta, GA 1992 - 1995 - Sr. Director Pharm R&D Warner-Lambert Company - Morris Plains, NJ 1989 - 1992 - Section Director, OTC A.H. Robins Co. - Richmond, VA 1985 - 1989 - Group Manager, Controlled Release & Novel Delivery RP Scherer - Clearwater, FL 1983 - 1985 - Manager Pharm R&D Lederle Laboratories - American Cyanamid - Pearl River, NY 1981 - 1983 - Group Leader Medical University of South Carolina - Charleston, SC 1978 - 1981 - Assistant Professor, College of Pharmacy

Education:

University of North Carolina at Chapel Hill 1966 - 1978
BS Pharmacy, PhD, Pharmaceutics

Interests:

Volunteer with Habitat For Humanity Support of Juvenile Diabetes Research Foundation

Michael Williams - Winston-Salem, NC

Work:

Fed EX Grounds
Package Handler Wake Forest Baptist Health
Or Instrument tech Family Dollar
Cashier/Stocker

Education:

Forsyth Technical Community College - Winston-Salem, NC
Associates in Applied Science in Business Administration

Michael Williams - Winston-Salem, NC

Work:

Allegacy Federal Credit Union
Loan Interviewer Delivery On Time
Mailroom Clerk Webster Fine Art
Sales / Warehouse

Transdermal Administration Of (2S)-(4E)-N-Methyl-5-(3-(5-Isopropoxypyridin)Yl)-4-Penten-2-Amine

US Patent:

2010024, Sep 30, 2010

Filed:

Jul 30, 2008

Appl. No.:

12/671232

Inventors:

Merouane Bencherif - Winston-Salem NC, US
John W. James - Winston-Salem NC, US
Michael G. Williams - Winston-Salem NC, US
Johannes Antonius Maria Neelissen - Sodertalje, SE

Assignee:

TARGACEPT, INC. - Winston-Salem
ASTRAZENECA AB - Sodertalje

International Classification:

A61K 31/44, A61K 9/70, A61P 25/00, A61P 29/00

US Classification:

424449, 514349

Abstract:

The present invention generally relates to the transdermal administration of (2S)-(4E)-N-methyl-5-(3-(5-isopropoxypyridin)yl)-4-penten-2-amine, or pharmaceutically acceptable salts thereof. The transdermal administration can be effected using transdermal drug delivery devices, semi-solid dosage forms, or iontophoresis. The drug delivery devices and/or semi-solid dosage forms can provide instantaneous release, sustained release, or combinations thereof, and can include permeation enhancers and other components to assist in drug transport across the dermis, especially the epidermis. The compositions can be used to treat and/or prevent any indication which the active ingredients are capable of treating and preventing, but deliver (2S)-(4E)-N-methyl-5-(3-(5-isopropoxypyridin)yl)-4-penten-2-amine, or pharmaceutically acceptable salts thereof, in an efficacious manner. Disorders that can be treated and/or prevented include central nervous system disorders, addictions, pain, and inflammation.